Home
Conditions
Neuroectodermal Tumors, Primitive, Peripheral

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

501 public trials 99 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Not Yet Recruiting

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

NCT06798532

Conditions: Ganglioneuroblastoma, Ganglioneuroma, Neoplasms, +11 more
Locations: CHU d'Amiens Amiens, France

CHU de Besançon Besançon, France

CHU de Bordeaux Bordeaux, France

CHU de Brest Brest, France

View all 27 locations

View Trial Details

Not Yet Recruiting

Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.

NCT07111117

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Institut Curie Paris, France

Hôpital Armand Trousseau Paris, France

Gustave Roussy Villejuif, France

View Trial Details

Not Yet Recruiting

GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.

NCT07090538

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital Beijing, China

Department of Pediatrics, The First Medical Center, Chinese PLA General Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

NCT06948994

Conditions: Autologous NK Cell, GD2 Antibody, Neoplasms, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

NCT06873672

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +46 more
Locations: Guizhou Medical University Guiyang, Guizhou, China

View Trial Details

Not Yet Recruiting

Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models

NCT06822842

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease, Female Urogenital Diseases, +33 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

NCT06047535

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Determining Patterns In Study Experiences of Neuroblastoma Patients

NCT05918432

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

NCT05303727

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

NCT01875601

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +19 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Neuroectodermal Tumors, Primitive, Peripheral

Neuroectodermal Tumors, Primitive, Peripheral trial results

Related conditions